Cash & equivalents increased 35.8%
Cash & equivalents changed +35.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$317.0M→$430.4M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DIOD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 254.6%
Operating income changed +254.6% from the comparable as-filed period.
$9.4M→$33.3M3 prior comparisons
Operating margin moved 491 bp higher
Operating margin changed +491 basis points from the comparable as-filed period.
2.56%→7.47%3 prior comparisons
Revenue increased 21.7%
Revenue changed +21.7% from the comparable as-filed period.
$366.2M→$445.5M3 prior comparisons
Inventory / revenue moved 1856 bp lower
Inventory / revenue changed -1856 basis points from the comparable as-filed period.
131.81%→113.25%3 prior comparisons
Gross profit increased 28.0%
Gross profit changed +28.0% from the comparable as-filed period.
$115.3M→$147.6M3 prior comparisons
Stock-based compensation increased 94.9%
Stock-based compensation changed +94.9% from the comparable as-filed period.
$5.8M→$11.3M3 prior comparisons
Gross margin moved 163 bp higher
Gross margin changed +163 basis points from the comparable as-filed period.
31.49%→33.12%3 prior comparisons
Debt decreased 17.1%
Debt changed -17.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$26.4M→$21.9M4 prior comparisons
Selling, general & administrative increased 17.3%
Selling, general & administrative changed +17.3% from the comparable as-filed period.
$59.5M→$69.8M3 prior comparisons
Net income increased 1.2%
Net income changed +1.2% from the comparable as-filed period.
$46.1M→$46.6M3 prior comparisons
SBC / revenue moved 95 bp higher
SBC / revenue changed +95 basis points from the comparable as-filed period.
1.58%→2.53%3 prior comparisons
Research & development increased 0.3%
Research & development changed +0.3% from the comparable as-filed period.
$40.5M→$40.7M3 prior comparisons
Inventory increased 4.5%
Inventory changed +4.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$482.7M→$504.6M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.